R Lou, W Shui - Molecular & Cellular Proteomics, 2024 - ASBMB
Data-independent acquisition (DIA) mass spectrometry (MS) has emerged as a powerful technology for high-throughput, accurate, and reproducible quantitative proteomics. This …
R Lou, Y Cao, S Li, X Lang, Y Li, Y Zhang… - Nature …, 2023 - nature.com
A plethora of software suites and multiple classes of spectral libraries have been developed to enhance the depth and robustness of data-independent acquisition (DIA) data …
AL George, FR Sidgwick, JE Watt… - Journal of Proteome …, 2023 - ACS Publications
Thermal proteome profiling (TPP) provides a powerful approach to studying proteome-wide interactions of small therapeutic molecules and their target and off-target proteins …
Y Zhang, X Cai, W Ge, D Wang, G Zhu… - Journal of proteome …, 2021 - ACS Publications
RT-PCR is the primary method to diagnose COVID-19 and is also used to monitor the disease course. This approach, however, suffers from false negatives due to RNA instability …
Y Sun, L Li, Y Zhou, W Ge, H Wang, R Wu… - Molecular …, 2022 - Wiley Online Library
Thyroid nodules occur in about 60% of the population. A major challenge in thyroid nodule diagnosis is to distinguish between follicular adenoma (FA) and carcinoma (FTC). Here, we …
Data independent acquisition mass spectrometry (DIA-MS) has recently emerged as an important method for the identification of blood-based biomarkers. However, the large …
Y Yang, Q Fang - Nature Communications, 2024 - nature.com
Deep learning has achieved a notable success in mass spectrometry-based proteomics and is now emerging in glycoproteomics. While various deep learning models can predict …
Z Xue, T Zhu, F Zhang, C Zhang, N Xiang, L Qian, X Yi… - Patterns, 2023 - cell.com
A comprehensive pan-human spectral library is critical for biomarker discovery using mass spectrometry (MS)-based proteomics. DPHL v. 1, a previous pan-human library built from …
Y Zeng, Y Li, W Zhang, H Lu, S Lin, W Zhang… - Cell …, 2024 - Wiley Online Library
COVID‐19 has been a global concern for 3 years, however, consecutive plasma protein changes in the disease course are currently unclear. Setting the mortality within 28 days of …